Key result
Losartan administration for 12 weeks reduced mean systolic and diastolic blood pressure from 159.0/100.7 mmHg to 130.7/85.9 mmHg in patients with stage 1 to 3 hypertension.
Why the study?
Does losartan reduce blood pressure and improve quality of life in patients with stage 1 to 3 hypertension?
Does losartan reduce blood pressure and improve quality of life in patients with stage 1 to 3 hypertension?
Losartan is an effective and well-tolerated initial antihypertensive agent that significantly lowers blood pressure in patients with stage 1 to 3 hypertension.
Answers are grounded in this paper and cite their sources.
Losartan was associated with BP reduction in stage 1-3 hypertension; leaves open first-line role pending randomized confirmation.
Background:Losartan potassium, one of an orally active, selective type 1 angiotensin Ⅱ receptor blocker, has been introduced recently as an antihypertensive agent.Method:Losartan, angiotensin Ⅱ receptor blocker, was administrated as an initial antihypertensive agent over 12 weeks in 30 patients (11 male, 19 female, 60.1±7.2years) with stage 1 to 3 hypertension in order to observe the clinical effects.Changes in quality of life, side effects, electrocardiogram and left ventricular function were also evaluated before and after losartan therapy.Results:1) After 12 weeks treatment with 50 to 100 mg of losartan, blood pressure was lowered markedly in 18 (60%), moderately in 9 (30%) and mildly in 1 (3%) out of 30 patients studied.The average of blood pressures of the 30 subjects were systolic 159.0±13.2mmHg and diastolic 100.7±9.4 mmHg before treatment, which were lowered to 130.7±15.6 and 85.9±9.1 mmHg respectively after 12 weeks (p<0.005).2) Heart rates were not changed with losartan.3) Quality of life including general well-being, physical symptom, sleep and sexual dysfunction improved markedly in 2 (7%) and slightly in 17 (57%) out of 30 subjects.4) Laboratory findings revealed no significant changes.5) In electrocardiographic and echocardiographic follow-up 1 patient with ST-T abnormality and 2 patients with mild LV systolic dysfunction improved to normal.6) Undesirable side effects were observed in 2 cases with dizziness, 1 dry cough, 1 skin rash, 1 leg edema and 1 epigastric discomfort, among whom one with dizziness stopped losartan.7) In the final clinical assessment according to the scores of hypotensive effect, quality of life, LV function and side effect, losartan was very useful in 3 (10%), useful in 18 (60%) and slightly useful in 3 (10%) out of 30 hypertensive patients.Conclusion:Losartan can be used as an effective initial agent for the treatment of hypertension of various severities with the improvement of quality of life and low side effects.( ( ( (Korean Circulation J 1998 ; 28( ( ( (8) ) ) ) : 1299-1306) ) ) ) KEY WORDS:Hypertension•Losartan•Angiotensin Ⅱ receptor blocker.논문접수일:1998년 6월 22일 심사완료일:1998년 8월 21일 교신저자:정명호, 501-191 광주광역시 동구 학1동 8번지 전남대학교병원 순환기내과 전화:(062) 220-6243•전송:(062) 228-7174 E-mail:myungho@chollian.net
No takes yet. Share an insight, caveat, or question.
Kim et al. (1998) studied stage 1 to 3 hypertension (n=30). Losartan was evaluated on blood pressure (p=<0.005). Losartan administration for 12 weeks reduced mean systolic and diastolic blood pressure from 159.0/100.7 mmHg to 130.7/85.9 mmHg in patients with stage 1 to 3 hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: